v3.20.2
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development 1,286 785 2,506 1,230
Sales and marketing 35 46 86 103
Depreciation and amortization 71 43 142 73
General and administrative 1,746 2,101 3,679 3,956
Total operating expenses 3,138 2,975 6,413 5,362
Loss from operations (3,138) (2,975) (6,413) (5,362)
Other income (expense):        
Interest expense 0 0 0 (823)
Interest income 2 2 6 3
Total other income (expense) 2 2 6 (820)
Net loss (3,136) (2,973) (6,407) (6,182)
Dividend to Series A and B preferred stockholders 0 0 0 (160)
Net loss attributable to common stockholders $ (3,136) $ (2,973) $ (6,407) $ (6,342)
Net loss per common share, basic and diluted (in dollars per share) $ (0.19) $ (0.20) $ (0.38) $ (0.56)
Weighted average number of common shares outstanding, basic and diluted (in shares) 16,858,367 14,801,116 16,819,789 11,292,738

Source